Skip to main content

Table 1 Patient characteristics

From: A comparison of immediate release and delayed release cysteamine in 17 patients with nephropathic cystinosis

Number of patients

17

Age (yr)

22.8 ± 10.5

Children (between 2 and < / = 12)

3

Adolescents (between > 12 and < / = 21)

6

Adults (> 21)

8

Male

13

Weight (kg)

55.3 ± 21.1

Single dose of IR-Cysteamine (Cystagon®)

550.7 ± 159.6

Single dose of DR-Cysteamine (Procysbi®)

741.2 ± 203.5